These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30043609)

  • 21. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
    Sader HS; Streit JM; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2004 Nov; 50(3):201-4. PubMed ID: 15541606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
    J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warning: spread of NDM-1 in two border towns of Iran.
    Armin S; Fallah F; Azimi L; Samadi Kafil H; Ghazvini K; Hasanzadeh S; Karimi A
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):125-129. PubMed ID: 30084804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
    Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
    Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S; Vickers A; Woodford N; Livermore DM
    J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
    Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
    Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
    J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Lee S; Razqan GS; Kwon DH
    Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the
    Avery LM; Abdelraouf K; Nicolau DP
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.
    MacVane SH
    J Intensive Care Med; 2017 Jan; 32(1):25-37. PubMed ID: 26772199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria.
    Ito A; Kohira N; Bouchillon SK; West J; Rittenhouse S; Sader HS; Rhomberg PR; Jones RN; Yoshizawa H; Nakamura R; Tsuji M; Yamano Y
    J Antimicrob Chemother; 2016 Mar; 71(3):670-7. PubMed ID: 26645269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
    Córdoba J; Coronado-Álvarez NM; Parra D; Parra-Ruiz J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7316-9. PubMed ID: 26369956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria.
    Otsuka Y
    Chem Pharm Bull (Tokyo); 2020; 68(3):182-190. PubMed ID: 32115524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].
    Ciftci IH; Aşık G; Karakeçe E; Oksüz L; Yağcı S; Sesli Çetin E; Ozdemir M; Atasoy AR; Koçoğlu E; Gül M; Kurtoğlu MG; Köksal Çakırlar F; Seyrek A; Berktaş M; Gültepe B; Ayyildiz A
    Mikrobiyol Bul; 2013 Oct; 47(4):592-602. PubMed ID: 24237428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.
    Zarrilli R; Giannouli M; Tomasone F; Triassi M; Tsakris A
    J Infect Dev Ctries; 2009 Jun; 3(5):335-41. PubMed ID: 19759502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India.
    Tiwari V; Kapil A; Moganty RR
    Microb Pathog; 2012 Aug; 53(2):81-6. PubMed ID: 22610043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii.
    Godeux AS; Lupo A; Haenni M; Guette-Marquet S; Wilharm G; Laaberki MH; Charpentier X
    J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30012729
    [No Abstract]   [Full Text] [Related]  

  • 40. Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria.
    Yarlagadda V; Manjunath GB; Sarkar P; Akkapeddi P; Paramanandham K; Shome BR; Ravikumar R; Haldar J
    ACS Infect Dis; 2016 Feb; 2(2):132-9. PubMed ID: 27624964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.